Skip to main content
AAPS PharmSci logoLink to AAPS PharmSci
. 1999 Oct 24;1(4):1–4. doi: 10.1208/ps010416

Monoamine oxidase inhibitory properties of some benzazoles: Structure-; Activity relationships

Teresa Grandi 1, Fabio Sparatore 1, Carmela Gnerre 2, Patrizia Crivori 2, Pierre-Alain Carrupt 2, Bernard Testa 2,
PMCID: PMC2751346  PMID: 11741212

Abstract

Benzazoles containing two or three nitrogen atoms were screened for their inhibitory activity toward monoamine oxidases MAO-A and MAO-B. In order to clarify the mechanism of interaction of these compounds with the enzyme, their electronic structure was calculated at the ab initio level and the influence of lipophilicity on activity was investigated. The mode of binding of benzazoles to MAO-B appears different from that of previously investigated heterocycles.

References

  • 1.Shih JC. Molecular basis of human MAO A and B. Neuropsychopharm. 1991;4:1–7. [PubMed] [Google Scholar]
  • 2.Gargalidis-Moudanos C, Remaury A, Parini A. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tube: regulation by 12 imidazoline ligands in intact cells. Mol Pharmacol. 1997;51:637–643. doi: 10.1124/mol.51.4.637. [DOI] [PubMed] [Google Scholar]
  • 3.Castagnoli K, Palmer S, Anderson A, Bueters T, Castagnoli N. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Chem Res Toxicol. 1997;10:364–368. doi: 10.1021/tx970001d. [DOI] [PubMed] [Google Scholar]
  • 4.Thull U, Testa B. Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases. Biochem Pharmacol. 1994;47:2307–2310. doi: 10.1016/0006-2952(94)90271-2. [DOI] [PubMed] [Google Scholar]
  • 5.Paglietti G, Sparatore F. Preparazione di acidi bbenzotriazolilbutirrici variamente sostituiti quali potenziali coleretici. Farmaco. 1972;27:380–396. [PubMed] [Google Scholar]
  • 6.Crowther AF, Curd FHS, Davey DG, Stacey GJ. Synthetic antimalarials. Part XXXIX. Sialkylaminoalkylaminoquinolines. J Chem Soc. 1949;1260–1271.
  • 7.Weissbach H, Smith TE, Daly JW, Witkop B, Udenfriend S. A rapid spectrophotometric assay of monoamine oxidase based on the rate of disappearance of kynuramine. J Biol Chem. 1960;235:1160–1163. [PubMed] [Google Scholar]
  • 8.Thull U, Kneubühler S, Testa B, Borges MFM, Pinto MMM. Substituted xanthones as selective and reversible monoamine oxidase A (MAO-A) inhibitors. Pharm Res. 1993;10:1187–1190. doi: 10.1023/A:1018924503552. [DOI] [PubMed] [Google Scholar]
  • 9.Dearden JC, Bresnen GM. The measurement of partition coefficients. Quant. Struct-Act Relat. 1988;7:133–144. doi: 10.1002/qsar.19880070304. [DOI] [Google Scholar]
  • 10.DAYLIGHT Software 4.41, Daylight Chemical Information System, Inc, Irvine, California: 1995.
  • 11.Wouters J, Ooms F, Jegham S, Koenig JJ, George P, Durant F. Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocyclic compounds. Eur J Med Chem. 1997;32:721–730. doi: 10.1016/S0223-5234(97)88914-3. [DOI] [Google Scholar]
  • 12.Steyaert G, Lisa G, Gaillard P, Boss G, Reymond F, Girault HH, Carrupt PA, Testa B. Intermolecular forces expressed in 1,2-dichloroethane/ water partition coefficient: a solvatochromic analysis. J Chem Soc. 1997;93:401–406. [Google Scholar]
  • 13.Chopineaux-Courtois V, Reymond F, Bouchard G, Carrupt PA, Testa B, Girault HH. Effects of charge and of intramolecular structure on the lipophilicity of nitrophenols. J Am Chem Soc. 1999;121:1743–1747. doi: 10.1021/ja9836139. [DOI] [Google Scholar]
  • 14.Wouters J, Durant F, Champagne B, André JM. Electronic properties of flavins implications on the reactivity and absorption properties of flavoproteins. Int J Quant Chem. 1997;64:721–733. doi: 10.1002/(SICI)1097-461X(1997)64:6<721::AID-QUA9>3.0.CO;2-Y. [DOI] [Google Scholar]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES